Selfapy GmbH, the Germany based provider in digital therapeutics for mental health disorders, has raised EUR 7m in a funding round led by Medice Arzneimittel Pütter GmbH & Co. KG, the Germany based pharmaceutical company focused on the treatment of ADHD, with participation from SHS, Think.Health Ventures, IBB Ventures, and HTGF.
Target – Selfapy GmbH